Reading Time: < 1 minuteAbstract Amyotrophic lateral sclerosis (ALS) inexorably impairs motor neuron function, culminating in progressive skeletal muscle atrophy and weakness among American males, who comprise approximately 60% of U.S. ALS diagnoses. This multicenter, double-blind, placebo-controlled randomized controlled trial (RCT) evaluated Norditropin® (somatropin, …

